These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3933540)

  • 21. Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis.
    Lombardi ML; de Angelis E; Rossano F; Ruocco V
    Dermatology; 1993; 186(2):118-22. PubMed ID: 8428039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
    Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Skriver L; Danø K
    FEBS Lett; 1986 Feb; 196(2):269-73. PubMed ID: 3081367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo.
    Krishnamurti C; Alving BM
    Semin Thromb Hemost; 1992 Jan; 18(1):67-80. PubMed ID: 1374195
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA; Stone OL
    Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.
    Lindahl TL; Ohlsson PI; Wiman B
    Biochem J; 1990 Jan; 265(1):109-13. PubMed ID: 2105714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts.
    Agis H; Bauer M; Knebl G; Watzek G; Gruber R
    J Periodontal Res; 2008 Jun; 43(3):334-42. PubMed ID: 18447857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
    Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
    J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U; Holmberg L; Bladh B; Astedt B
    Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
    Schleef RR; Wagner NV; Loskutoff DJ
    J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
    Colucci M; Paramo JA; Stassen JM; Collen D
    J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine.
    Pelayo BA; Fu YM; Meadows GG
    Int J Oncol; 2001 Apr; 18(4):877-83. PubMed ID: 11251188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a reversible inhibitor of plasminogen activators in blood plasma.
    Kluft C; Jie AF; Sprengers ED; Verheijen JH
    FEBS Lett; 1985 Oct; 190(2):315-8. PubMed ID: 3930295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of proteases type plasminogen activator and their inhibitor in cornea.
    Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
    Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.